ACIP review of the hepatitis B birth dose vaccination remains a grave concern - Please read more here.

Site Search

You searched for "hepatitis D"

  • You Cannot Live Without Your Liver: Celebrating World Liver Day

    What is your body’s largest internal organ that filters and extracts toxins from your blood and can even regenerate on its own?   The liver!  Although the liver may not be discussed as frequently as the brain or heart, the liver is an incredibly critical part of everyday life and plays a role in metabolism, digestion, immunity, and overall keeping the body healthy. On April 19th we celebrate World Liver Day and honor everything it does for our bodies. Just some of the liver’s major roles include the production of bile (which helps break down fats during digestion), detoxification of the blood supply, and storage of essential vitamins (Kalra et al., 2023). The complex involvement of the liver in all these functions means that any injury or damage can cause a cascade of negative consequences. That being said, there are many useful preventative and curative measures that people can utilize to heal the liver. In this post, we gained insight from liver experts, clinicians, and people with lived experience to highlight the good, the bad, and the healthy for all things liver!  Liver Disease  So, what exactly causes someone to get a liver disease?   It all boils down to tissue damage which can be caused by viral infections, excessive alcohol consumption and fat intake, autoimmune disease, and more.  Viral infections  Of course, one of the most common diseases that affects the liver is hepatitis in all its forms. Hepatitis translates to inflammation of the liver, which can be caused by viral infections, excessive alcohol consumption, or autoimmune diseases. Regarding viral infections there are five different hepatitis viruses (A, B, C, D, and E) that can damage the liver. Dr. Su Wang, Senior Advisor for Global Health for the Hepatitis B Foundation and health care provider, explains the mechanism for viral liver damage.  “The virus resides and replicates in the liver and over time can cause chronic inflammation which can lead to fibrosis [mild scarring] and

    http://www.hepb.org/blog/cannot-live-without-liver-celebrating-world-liver-day/
  • Time to End the Military's Ban on Enlistees with Hepatitis B

    Image courtesy of vectorolie at FreeDigitalPhotos.net. By Christine Kukka One of the most glaring civil rights abuses facing people with hepatitis B in the United States today is the military’s continued refusal to allow anyone with chronic hepatitis B to enlist. This prohibition continues, despite the fact that all military personnel are vaccinated against hepatitis B, and scientific data shows hepatitis B is not spread through casual contact. “Our brave servicemen and women deserve nothing less than the best, yet many qualified individuals are being prevented from serving in specific roles and/or being promoted within the military’s ranks. That’s simply wrong,” said U.S. Rep. Barbara Lee, D-Calif., in a letter challenging the military’s Uniform Code of Military Justice prohibits people with hepatitis B and C and HIV from enlisting in the Navy, Army, Air Force, Coast Guard, Marine Corps and National Oceanic and Atmospheric Administration. This outdated and scientifically-baseless Department of Defense policy damages the civil liberties of many Americans. Asian and Pacific Islander Americans, African and Middle Eastern immigrants and other ethnic groups are disproportionately impacted by hepatitis B. For example, Asian-Americans make up less than 5 percent of the total U.S. population but account for more than 50 percent of the 2 million people living with hepatitis B cases in the U.S. Immigrants and their children are also disproportionately affected by hepatitis B, due to the lack of vaccinations in their countries of origin. As a result, they are barred from military service, which offers a path to citizenship. What is especially heart-breaking are the young men and women who work hard to get into prestigious military academies, only to be dismissed when it’s discovered they have hepatitis B. This military code historically barred people with serious medical conditions because they were considered unfit to serve, suspected to incur high healthcare

    http://www.hepb.org/blog/time-end-militarys-ban-enlistees-hepatitis-b/
  • Taking Antivirals Long-Term for Hepatitis B? Should You Worry About Bone Loss?

    Image courtesy of Sira Anamwong at FreeDigitalPhotos.net. By Christine Kukka To prevent liver damage and cirrhosis and reduce the risk of liver cancer--especially in older patients who’ve had hepatitis B for decades--doctors often prescribe long-term antiviral treatment. But some antivirals cause minor bone loss, which poses a problem for older patients with osteoporosis. According to experts, the risk of bone loss from long-term antiviral treatment is low, and in fact some antivirals do not cause any bone loss at all. But if you are starting antivirals at an older age, or if you have been on antivirals long-term, experts recommend you monitor your potassium and vitamin D levels and regularly test for bone loss in the hip area so you know if you are experiencing bone loss and need a calcium or vitamin D supplement. Antivirals affect bone health by causing a reduction in the amount of phosphorus in your body; a mineral that is essential to bone health. Historically, the antivirals lamivudine (Epivir-HBV) and adefovir (Hepsera) were widely used and adefovir specifically was linked to bone loss. Neither of those antivirals are currently recommended for first-line treatment. Today, the antivirals entecavir and tenofovir are recommended for most patients. Here is how these two antivirals affect bone health. Entecavir (Baraclude) appears to cause no bone loss, according to hepatitis B expert Dr. Robert Gish, medical consultant to the Hepatitis B Foundation and professor consultant of gastroenterology and hepatology at Stanford University. This antiviral, which recently became available as a less-expensive generic, has proven highly effective in reducing viral load (HBV DNA) and reducing liver damage in patients who are taking an antiviral for the first time. If you are an older patient, have signs of bone loss, and have never been treated with an antiviral before, your doctor may recommend this daily antiviral pill. However, entecavir is not an option if you’ve

    http://www.hepb.org/blog/taking-antivirals-long-term-should-you-worry-about-bone-loss/
  • Buyer Beware: When Someone Claims to Have a Hepatitis B Cure, It's a Counterfeit Drug

    … its extract silymarin. The NIH milk thistle report found, “Previous laboratory studies suggested that milk thistle may benefit the liver by protecting and promoting the growth of liver cells, fighting oxidation (a chemical process that can damage cells), and inhibiting inflammation. However, results from small clinical trials of milk thistle for liver diseases have been mixed, and two rigorously designed studies found no benefit.” A true scientific evaluation is what we need to hear, even when we desperately want milk thistle or another supplement to be the cure. There is no magic bullet that is going to cure hepatitis B. It is a complex infection with no cure at this time. Experts are making great strides and hope to find a cure in the next few years, but now, this is the time to let our heads make healthcare decisions, instead of our vulnerable and hopeful hearts. So be patient. Don’t fall for false promises, even when they’re accompanied by professional-looking photographs and emotional testimonials. If it sounds too good to be true, it probably is. More information about counterfeit medications: Quality Matters: Battling the Epidemic of Illegal Online Drug Sellers and Counterfeit Medicines  Of the 35,000-50,000 active online drug sellers, 97 percent do not comply with U.S. laws and 50 percent of medicines sold online are fake or counterfeit, according to the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit headquartered in Washington, D.C. with operations in Europe and Asia. These counterfeit medications are often manufactured in unsafe conditions; contain too little, too much or no active pharmaceutical ingredients; and, in many cases, have been found to contain dangerous substances like floor wax, rat poison, concrete, chalk, boric acid, road tar, paint, anti-freeze, and other toxins. This means that consumers worldwide are just a click away from buying products that may cause harm, treatment failure or even death. Read

    http://www.hepb.org/blog/buyer-beware-when-someone-claims-to-have-a-hepatitis-b-cure-its-a-counterfeit-drug/
  • Shop Carefully for the Best Insurance Plan When You Have Hepatitis B

    Image courtesy of digitalart at FreeDigitalPhotos.net With the cost of health care and prescription drugs soaring, it’s important to choose health insurance carefully when you take hepatitis B medications and need frequent check-ups and lab tests. In the next two months, Medicare recipients, people who get insurance through their jobs and consumers buying coverage through the Affordable Care Act (Obamacare) will be selecting insurance plans during open enrollment. If you take antivirals or interferon and have frequent lab tests and doctor visits, it’s important that you select the plan that: Has your specialist or primary care doctor and lab in its network, And offers the lowest copay for the drugs you need. If you're 65 or older, finding the best Medicare plan is essential to your health and wallet, especially when you're on treatment. Medicare Part D covers prescription drugs. You select from numerous plans based on where you live and what drugs you take. For example, if you're shopping for a drug plan to cover tenofovir (Viread), plan prices can vary by more than $1,000 a year. You have until Dec. 7 to sign up for the Medicare coverage plan that will give you the best deal in 2016.  This is what Medicare offers: Part A is free. It covers most of hospital and nursing home care, however you still pay for some deductibles and copays. For example, if you go to a hospital for a liver biopsy, you will pay a portion of that cost if you only have Part A. Part B covers doctor visits, lab tests and even the hepatitis B vaccine. It costs about $104.90 a month and the amount rises with your Social Security income. There is a deductible and you pay a 20 percent copay for many services. Part D covers your drug costs and it's optional, but if you're on antivirals, interferon or other medications, it's critical. You pay about $60 a month for coverage and you shop online at the Medicare website for the drug plan that fits your prescription needs best. You'll have a

    http://www.hepb.org/blog/shop-carefully-for-the-best-insurance-plan-when-you-have-hepatitis-b/
  • Turkish

    To view or print the entire Turkish Chapter in English, as a single document click here. Turkce pdf If you do not have Adobe Acrobat Reader, download it here for free. Hepatit B Vakfı Web Sitesinin Türkçe Bölümüne Hoş Geldiniz Hepatit B sessiz bir hastalıktır ve çoğu kişi enfekte olduğunu bile bilmez. Bu web sitesi hepatit B önlenmesi, tanı konması ve takibi hakkında bilgiler içerir. Bu bilgileri arkadaşlarınız, aileniz ve toplumunuzdaki diğer kişilerle paylaşmanızı öneririz. Hepatit B hakkında bilmeniz gereken bazı önemli şeyler şunlardır: • Hepatit B kalıtsal değildir ve nedeni bir virüstür. 
• Sizi ömür boyu hepatit B'den koruyacak güvenli bir aşı vardır. 
• Hepatit B tanısını koymak için basit bir kan testi vardır. 
• Tedavi seçenekleri mevcuttur. Hepatit B Küresel bir HastalıktırHepatit B her yaş ve etnik kökenden kişileri enfekte edebilir ama dünyada hepatit B'nin daha sık görüldüğü yerler mevcuttur: örneğin Asya, Afrika ve Güney Amerika'nın bazı kısımları, Doğu Avrupa ve Orta Doğu'daki kişilerin enfekte olma riski çok daha yüksektir. Hepatit B bu bölgelerde doğan Amerikalılar (veya ebeveynleri buralarda doğmuş olanlar) arasında da sıktır. Dünya çapında hepatit B hastalığı olan yüzlerce milyon kişi vardır. Çoğu kişi enfekte olduğunu bilmez ve bir belirtisi yoktur – ama bilmeniz gereken birçok önemli şey bulunmaktadır. Hepatit B testi yaptırmanız yaşamınızı kurtarabilir. Hepatit B durumunuz olduğunu biliyorsanız karaciğerinizi sağlıklı tutmak için yaşam tarzı değişiklikleri yapabilir ve virüsü takip edip karaciğer hasarını önlemesi için bir doktoru görebilirsiniz. Hepatit B Vakfı, araştırma, eğitim ve hasta hakları savunuculuğu yoluyla dünya çapında hepatit B'den etkilenmiş herkes için tam bir tedavi bulmak ve yaşam kalitesini arttırmak amaçlı ulusal ve kar amacı gütmeyen bir örgüttür. Red Beyanı: Bu web sitesinde sağlanan bilgi sadece eğitim amacıyladır. Hepatit B Vakfı tıbbi bir örgüt değildir. Lütfen kişisel tıbbi bakım ve öneriler için doktorunuz veya vasıflı bir sağlık uzmanıyla konuşun. Welcome to the Turkish Chapter of the Hepatitis B Foundation Website Hepatitis B is known as a silent disease, and most people don’t even know they are infected. This website contains information about preventing, diagnosing and managing hepatitis B. We encourage you to share this information with your friends, family and others in your community. Here are some important things to remember about hepatitis B: • Hepatitis B is not inherited - it is caused by a virus. 
• There is a safe vaccine which will protect you from hepatitis B for life. 
• There is a simple blood test to diagnose hepatitis B. 
• There are treatment options. Hepatitis B is a Global DiseaseHepatitis B can infect any person of any age or ethnicity, but people from parts of the world where hepatitis B is common, such as Asia, parts of Africa and South America, Eastern Europe, and the Middle East, are at much higher risk for getting infected. Hepatitis B is also common among Americans who were born (or whose parents were born) in these regions. There are hundreds of millions of people worldwide who have hepatitis B. Most people don’t even know they are infected, and don’t have symptoms – but there are many important things you should know. Getting tested for hepatitis B can save your life. If you know you have hepatitis B, you can make lifestyle choices to keep your liver healthy and you can see a doctor to help manage the virus and prevent liver damage. The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and helping to improve the quality of life for all those affected by hepatitis B worldwide through research, education and patient advocacy. Disclaimer: The information that is provided on this website is for educational purposes only. The Hepatitis B Foundation is not a medical organization. Please talk to your doctor or a qualified health care provider for personal medical care and advice.

    https://www.hepb.org/languages/turkish/
  • Hepatitis B Foundation applauds HHS letter on discrimination against people living with hepatitis B who are pursuing careers in health care

    Doylestown, Pa., Nov. 6, 2020 -- The Hepatitis B Foundation applauds the U.S. Department of Health and Human Services (HHS) for issuing a letter to health professions schools in the U.S., calling for renewed attention to admissions and clinical placement policies and their obligation to comply with federal civil rights laws that protect the rights of people living with hepatitis B.  In the U.S., an estimated 2.2 million people are living with chronic hepatitis B infection. Stigma and discrimination related to hepatitis B are often caused by lack of public awareness and fears and misconceptions about the disease. Students living with hepatitis B seeking education and training to become health care providers often face discriminatory admission policies and practices.  The recent letter from Admiral Brett P. Giroir, assistant secretary for health, and Roger Severino, director of the HHS Office for Civil Rights, highlights current recommendations from the U.S. Centers for Disease Control and Prevention (CDC) for hepatitis B-infected health care providers and students. Those recommendations state, “HBV [hepatitis B] infection alone should not disqualify infected persons from the practice or study of surgery, dentistry, medicine, or allied health fields.” Director Severino added, “Because stigma attached to a disability can result in discriminatory exclusion, this is an important reminder about people’s rights and provider’s responsibilities under the law.” The message also reemphasizes nondiscrimination policies, including the Americans with Disabilities Act (ADA), Section 504 of the Rehabilitation Act, and Section 1557 of the Affordable Care Act, which prohibit discrimination against people living with hepatitis B. “This message from HHS leadership brings much-needed national attention to the continued discrimination students living with hepatitis B face,” Chari Cohen, DrPH, MPH, senior vice president of the Hepatitis B Foundation, said. “Despite federal protections, we continue to receive phone calls and letters from students around the country who face unjustified denial of school admission and enrollment or dismissal from academic programs because of their hepatitis B infection.” "The Hepatitis B Foundation, which has been fighting for the rights of people living with hepatitis B for nearly 30 years, is very pleased to have this new tool that will help students and health providers facing discrimination," Dr. Cohen said. "We are grateful to Admiral Giroir and Director Severino for prioritizing the rights of people living with hepatitis B." Discriminatory admissions policies at health care profession schools were revealed in 2011 when two students contacted the Hepatitis B Foundation for assistance when they were denied admission to medical schools because they had hepatitis B. The Foundation then alerted the U.S. Department of Justice, CDC and HHS, and helped coordinate the response that ultimately led to an agreement that people living with hepatitis B deserve protection under the ADA. In 2013, with support from and in collaboration with HHS and the U.S. Department of Education, a landmark settlement by the U.S. Department of Justice ruled the medical school had violated the Americans with Disabilities Act. The Hepatitis B Foundation encourages persons living with hepatitis B who experience discrimination at a school in the U.S. to file a complaint with the HHS Office for Civil Rights. Additional resources, including guidance for health profession schools to assess and create policies and practices that adhere to CDC recommendations and legal requirements are available here. Updated 11/09/20

    https://www.hepb.org/news-and-events/news-2/hepatitis-b-foundation-applauds-hhs-letter-on-discrimination-against-people-living-with-hepatitis-b-who-are-pursuing-careers-in-health-care/
  • Get Involved

    It is vital that we improve hepatitis B screening and access to care in our high-risk African communities. To do this, we need to work together! Everyone has an important role to play, from community and faith leaders, to health care providers, to business owners. Here are some of the things that you can do in your own communities: For Community Leaders and Community-Based Organizations Host a community health forum on hepatitis B. You can use the CHIPO Powerpoint presentations to introduce hepatitis B as a health issue that needs to be addressed. Find a local Hep B United coalition partner that conducts community screening and education in the U.S., and talk about how you can work together to conduct community events. Start the conversation! Talk to your friends, family members and colleagues about the importance of getting tested for hepatitis B. You can use our #justB storyteller videos to help start the conversation at events – watch Bunmi’s, William's, Bright's, Adama's, and FK's stories for inspiration! You can also check out some of the stories shared by some of our Nigerian storytellers - hear from Sonia, Ismail, John, Gold, and Dayo! Advocate for increased hepatitis B testing in your local community – talk to your health department, and local, city or state government officials to let them know that hepatitis B is an important health issue. Join CHIPO! There is strength in numbers, and we welcome all who are interested in helping us improve testing and care among African communities. Email beatrice.zovich@hepb.org to join our coalition.  For Individuals Get tested for hepatitis B! If you find that you are not infected, talk to your doctor about getting the hepatitis B vaccine to protect you. Because hepatitis B is more common among African communities, it is important that people who were born in Africa, or whose parents were born in Africa, be tested for hepatitis B infection. Hepatitis B is a silent disease, and most people feel well when they are infected, even when the virus is damaging their liver. The CDC has a quick and simple risk assessment that you can take to help you figure out whether you should be tested for hepatitis B. If you find out that you are living with hepatitis B, don't be afraid! People living with hepatitis B often live long and healthy lives. Visit our Newly Diagnosed page for tips and next steps.  

    https://www.hepb.org/research-and-programs/chipo/get-involved/

  • Гепатит Б Сангийн вэб хуудасны Монгол хэл дээрх хувилбарт тавтай морилно уу Гепатит Б нь чимээгүй өвчин учир ихэнх хүмүүс халдвар авснаа ч мэддэггүй. Энэхүү вэб хуудас нь гепатит Б-ээс хэрхэн урьдчилан сэргийлэх, оношлох, эмчлэх талаарх мэдээллийг өгөхөд чиглэсэн. Танаас өөрийн найз нөхөд, гэр бүл болон бусад дотны хүмүүстэйгээ уг мэдээллийг хуваалцахыг хүсье. Гепатит Б вирусын талаар зарим зайлшгүй мэдэх ёстой зүйлс: Гепатит Б вирус нь удамшдаггүй харин вирусаар үүсгэгддэг. 
 Гепатит Б вирусаас бүхий л амьдралын тань турш хамгаалах вакцин байдаг. 
 Энгийн цусны шинжилгээгээр гепатит Б вирусыг оношилж болно. 
 Эмчилгээний аргачлалууд байдаг. Гепатит Б бол дэлхий нийтийн өвчинГепатит Б нь аль ч насны ямар ч хүнд гарал угсаа хамааралгүй халдварлаж болно. Гэвч Ази, Африк болон Өмнөд Америкийн зарим хэсгүүд, Зүүн Европ, Ойрхи Дорнодын улс орнуудад нийтлэг ажиглагддаг бөгөөд халдварлах магадлал ч өндөр байдаг. Түүнчлэн Гепатит Б нь өөрөө болон эцэг эх нь тус бүс нутгуудад төрсөн Америкчуудын дунд нийтлэг ажиглагддаг. Дэлхий дахинд гепатит Б халдвар авсан олон сая хүмүүс байдаг боловч тэдний ихэнх нь халдвар авснаа мэддэггүй. Тэдэнд ямарваа нэгэн халдварын шинж тэмдэг илэрдэггүй, гэсэн хэдий ч зайлшгүй мэдэх ёстой олон зүйл байдаг. Гепатит Б-г оношлуулснаар та амьдралаа аварч чадна. Хэрвээ та гепатит Б вирустай гэдгээ мэдэж байвал та өөрийн элгийг эрүүл байлгах амьдралын хэв маягийг сонгож болох ба эмчид үзүүлж вирус таны элгийг гэмтээхээс сэргийлэх боломжтой. Гепатит Б Сан нь үндэсний ашгийн бус байгууллага бөгөөд судалгаа шинжилгээ, эрүүл мэндийн боловсрол болон зөвлөгөө мэдээллээр дамжуулан дэлхий дахинаа гепатит Б-ээр халдварласан олон сая хүмүүсийн амьдрах чадварыг дээшлүүлэх, эмчлэх арга замыг хайхад нь туслахад чиглэсэн байгууллага юм. Тайлбар: Тус вэбсайтын мэдээллүүд нь зөвхөн эрүүл мэндийн боловсрол олгох зорилготой. Гепатит Б Сан нь эрүүл мэндийн байгууллага биш болно. Та өөрийн эрүүл мэнд болон эмчилгээний талаар эмчтэйгээ зөвлөлдөж зөвлөгөө авна уу. Welcome to the Mongolian Chapter of the Hepatitis B Foundation Website Hepatitis B is known as a silent disease, and most people don’t even know they are infected. This website contains information about preventing, diagnosing and managing hepatitis B. We encourage you to share this information with your friends, family and others in your community. Here are some important things to remember about hepatitis B: Hepatitis B is not inherited - it is caused by a virus. 
 There is a safe vaccine which will protect you from hepatitis B for life. 
 There is a simple blood test to diagnose hepatitis B. 
 There are treatment options. Hepatitis B is a Global DiseaseHepatitis B can infect any person of any age or ethnicity, but people from parts of the world where hepatitis B is common, such as Asia, parts of Africa and South America, Eastern Europe, and the Middle East, are at much higher risk for getting infected. Hepatitis B is also common among Americans who were born (or whose parents were born) in these regions. There are hundreds of millions of people worldwide who have hepatitis B. Most people don’t even know they are infected, and don’t have symptoms – but there are many important things you should know. Getting tested for hepatitis B can save your life. If you know you have hepatitis B, you can make lifestyle choices to keep your liver healthy and you can see a doctor to help manage the virus and prevent liver damage. The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and helping to improve the quality of life for all those affected by hepatitis B worldwide through research, education and patient advocacy. Disclaimer: The information that is provided on this website is for educational purposes only. The Hepatitis B Foundation is not a medical organization. Please talk to your doctor or a qualified health care provider for personal medical care and advice.

    https://www.hepb.org/languages/mongolian/
  • Board of Directors & Staff

    LEADERSHIP Chari A. Cohen, DrPH, MPH (bio)President Louis P. Kassa, III, MPA (bio)Chief Executive Officer Robert Gish, MD (bio)Medical Director Su Wang, MD, MPH, FACPSenior Advisor for Global Health Robert Christmas (bio)Chief Operating Officer Jean Holmes, MBA (bio)Vice President, Institutional Advancement Edward F. Tate III, MS (bio)Director, Communications & Marketing BOARD OFFICERS Timothy M. Block, PhDCo-founder and Chair  Louis P. Kassa, III, MPAChief Executive Officer Chari A. Cohen, DrPH, MPHPresident Catharine Williams, MGAVice Chair Joel Rosen, EsqVice Chair Elizabeth "Betsy" Seeber, MBA, CPA, FHFMATreasurer Wayne YetterSecretary Board of Directors Timothy M. Block, PhD, (bio)Co-founder and Chair  Stanley BroadbentRetired Managing Director, The Glenmede Trust Carol Brosgart, MDClinical Prof. of Medicine, UC San Francisco Nathaniel Brown, MDRetired biotech/pharma executive (focus on HBV and HCV) Chari A. Cohen, DrPH, MPHPresident, Hepatitis B Foundation  Loren Danzis, EsqPartner, Fox Rothschild LLP Craig Esterly, MBACo-founder and managing memberSD Asset Group Anthony Ford-Hutchinson, PhDFormer senior VP, vaccine researchMerck & Co. David A. Gruber, CPAOwner, Gruber Administrative Services, LLC Raman KapurChairman, Transition Patient Services, LLC Louis P. Kassa III, MPACEO, Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC); President of the PABC Mark PettyOperating Partner, Tinicum, LP Lewis Roberts, MB, ChB, PhDProfessor of Medicine, Mayo Clinic Joel Rosen, EsqVice Chair EmeritusManaging PartnerHigh Swartz Attorneys at Law Betsy Seeber, MBA, CPA, FHFMAVice President and Chief Financial OfficerDoylestown Health Thomas Shenk, PhDElkins Professor, Dept. of Molecular BiologyPrinceton University Elizabeth D. Sigety, EsqPartner, Fox Rothschild LLP  Walter Tsou, MD, MPHAdjunct Professor, University of PennsylvaniaFormer City Health Commissioner of Philadelphia Su Wang, MD, MPH, FACPMedical Director, Center for Asian HealthCatharine Williams, MGAVice Chair Wayne YetterFounding CEO of Astra Merck and Novartis (USA)   Scientific and Medical Advisors Harvey Alter, MD Nobel LaureateFormer Chief, Infectious Disease Section, Transfusion Medicine, National Institutes of Health Timothy M. Block, PhD Co-Founder and President, Hepatitis B Foundation and Baruch S. Blumberg Institute Nathaniel Brown, MDRetired Biotech/Pharma Executive (focus on HBV and HCV), San Francisco Carol Brosgart, MDClinical Professor of Medicine, Division of Global Health, UC San Francisco Francis Chisari, MDNational Academy of SciencesNational Academy of MedicineProfessor EmeritusScripps Research Institute Raymond Dwek, DPhil, FRSProfessor and Founder, Glycobiology Institute at the University of Oxford, Oxford, UK Anthony Ford-Hutchinson, PhDFormer Merck Sr. VP, Vaccine Research Lawrence Friedman, MDGastroenterologist, Massachusetts General Hospital Don Ganem, MDProfessor Emeritus, UC San Francisco Robert G. Gish, MDMedical director, Hepatitis B Foundation, and principal, Robert G Gish Consulting LLC Hie-Won L. Hann, MDProfessor and director, Liver Disease Prevention Center, Thomas Jefferson University Hospital, Philadelphia Anna Lok, MDAlice Lohrman Andrews Research Professor of Hepatology, Director of Clinical Hepatology, Assistant Dean for Clinical Research, University of Michigan Brian McMahon, MDScientific and Clinical Director, Liver Disease and Hepatitis Program, Alaska Native Medical Center, Fairbanks, AK Edith Mitchell, MDProgram Leader, GI OncologyDirector, Center to Eliminate Cancer DisparitiesClinical Professor, Jefferson University Robert Perrillo, MDSenior Research Hepatologist, Hepatology Division of Baylor University Medical Center, Dallas, and Adjunct Professor of Medicine, University of Texas Southwestern  Lewis Roberts, MB, ChB, PhDProfessor of Medicine, Mayo Clinic Kenneth Rothstein, MDDirector of Regional Outreach and Regional HepatologyProfessor of Clinical MedicinePenn Medicine Raymond Schinazi, PhDProfessor, Pediatrics and Chemistry, and Director of the Laboratory of Biochemical Pharmacology, Emory University; Founder of RFS Pharma Thomas Shenk, PhDElkins Professor, Dept. of Molecular Biology, Princeton University John Tavis, PhDProfessor, Molecular Microbiology and ImmunologySaint Louis University School of Medicine Norah Terrault, MDProfessor, Chief of Gastroenterology and Liver Diseases, University of Southern California Scientific and Medical Advisory Board Members Emeritus Stephen Locarnini, MD, PhD Board Members Emeritus Joan Block, RN, BSN Alan Brownstein, MPH Joseph Hediger Janine Witte   Honorary Board Members Anne Blumberg Jane Blumberg   In Memoriam Baruch Blumberg, MD, DPhilNobel LaureateDistinguished Scholar of the Hepatitis B Foundation (2011) W. Thomas London, MDEmeritus, Fox Chase Cancer Center (2017) William Mason, PhDEmeritus, Fox Chase Cancer Center (2022) Bud Tennant, DVMCollege of Veterinary Medicine, Cornell University (2016)  Paul WitteCo-Founder (2021)   HEPATITIS B FOUNDATION Chari A. Cohen, DrPH, MPH President Su Wang, MD, MPH, FACPSenior Advisor for Global Health Jean Holmes, MBAVice President, Institutional Advancement Monique BenvenuttiSocial Media and Communications Manager Maura Delaney Development Associate  Catherine Freeland, MPH, PhD Associate Director, Public Health Research Florence Gune, MPH, MPAPublic Health Program Coordinator Frank HoodAssociate Director, Policy and Partnerships and Director, Hep B United  Yasmin Ibrahim, MD, PhD, MBASenior Program Manager, Public Health Michaela Jackson, MSProgram Director, Prevention Policy Maureen KamischkePatient Engagement and Consult Specialist Shreya KoiralaProgram Coordinator, Public Health  Megan Pierce, CMPDirector of Events Anousha QureshiProgram Coordinator, Public Health Rhea Racho, MPAProgram Director, Advocacy & Engagement Kara Sapp, MS, MPHPublic Health Program Coordinator Alaina SchukraftDevelopment Manager Edward F. Tate III, MSDirector, Communications & Marketing Beatrice Zovich, MPHProgram Manager, Public Health BLUMBERG INSTITUTE STAFF

    https://www.hepb.org/about-us/board-of-directors-and-staff/